Company Plant Advanced Technologies

Equities

ALPAT

FR0010785790

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Ratings for Plant Advanced Technologies

EPS Revisions

Annual profits - Rate of surprise

Sector Other Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 11:18:11 2024-04-26 am EDT			5-day change	1st Jan Change
10.5 ^EUR	0.00%		+2.94%	+24.26%

Jan. 09	Plant Advanced Technologies Announces the Official Launch of Its Latest Active Ingredient, Hydraqueen Exudactive®?1,3, and the Upcoming Cosmetic Range as Part of Its New Business Strategy	CI
2023	Plant Advanced Technologies SA Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Plant Advanced Technologies specializes in the identification, optimization and production of rare biomolecules for the pharmaceutical laboratories, cosmetic industries and green chemistry. The group has developed revolutionary production methods based on aeroponics growing plant (soilless). Innovative technologies (PAT plantes à traire - Patent INRA-University of Lorraine / INPL and PAT Friday) allow the identification of new rare molecules previously inaccessible and the industrial production.

Number of employees: 56

EUR in Million	2021	Weight	2022	Weight	Delta
Services and Work 66.3 %	1	48.6 %	1	66.3 %	+37.39%
Plant Molecules and Extracts 33.7 %	1	51.4 %	1	33.7 %	-33.95%

EUR in Million	2021	Weight	2022	Weight	Delta
France 100.0 %	2	100.0 %	2	100.0 %	+0.71%

Managers	Title	Age	Since
Frédéric Bourgaud FOU	Founder	59	05-06-29
Jean-Paul Fèvre CEO	Chief Executive Officer	70	05-06-29
Régis Brun DFI	Director of Finance/CFO	78	-
Paul Hannewald BRD	Director/Board Member	43	09-12-31

Members of the board	Title	Age	Since
Thierry Chapusot BRD	Director/Board Member	65	15-06-29
Viviane Neiter BRD	Director/Board Member	68	15-06-29
Jean-Paul Fèvre CEO	Chief Executive Officer	70	05-06-29
Régis Brun DFI	Director of Finance/CFO	78	-
Thierry Fevre BRD	Director/Board Member	67	-
Frédéric Bourgaud FOU	Founder	59	05-06-29
Michel Salmon BRD	Director/Board Member	-	18-06-26
Paul Hannewald BRD	Director/Board Member	43	09-12-31
Catherine Breffa BRD	Director/Board Member	-	20-06-29
Michael Donabédian BRD	Director/Board Member	-	20-06-29

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,092,715	561,918 ( 51.42 %)	0	51.42 %

Name	Equities	%	Valuation
Gay-Lussac Gestion SA 1.834 %	20,000	1.834 %	181 440 €
Allianz Global Investors GmbH (France) 0.009168 %	100	0.009168 %	907 €

Plant Advanced Technologies SA

19, avenue de la Forêt de Haye

54500, Vandoeuvre-les-Nancy

+33 3 83 94 03 42

http://www.plantadvanced.com

address Plant Advanced Technologies(ALPAT)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

10.5 EUR

Average target price

11.5 EUR

Spread / Average Target

+9.52%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
PLANT ADVANCED TECHNOLOGIES	+24.26%	12.18M
IQVIA HOLDINGS INC.	+1.51%	42.75B
LONZA GROUP AG	+49.22%	41.61B
MODERNA, INC.	+8.57%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B

Other Biotechnology & Medical Research